Full Press Release Details
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease.
BIIB
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
Key Takeaway: Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease